Omeprazol Amarox (Omeprazole)

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related conditions.

• Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis.
• Peptic ulcer disease: supports ulcer healing and reduces recurrence risk.
• Zollinger‑Ellison syndrome: controls excessive gastric acid secretion.
• Helicobacter pylori eradication regimens: used as adjunct therapy to improve eradication rates.
• NSAID‑associated ulcer prevention: lowers the risk of ulcer development in chronic NSAID users.

• Omeprazole selectively and irreversibly inhibits the H+/K+‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By blocking this final step of acid production, it markedly lowers gastric acidity, allowing mucosal healing and symptom control in acid‑related disorders.

Adverse reactions to omeprazole are generally mild to moderate and vary with duration of therapy.

Common Side Effects

• Headache: mild, transient headache reported by some patients.
• Diarrhea: loose stools occurring during early treatment.
• Nausea: occasional feeling of queasiness.
• Abdominal pain: mild discomfort in the stomach area.
• Flatulence: increased intestinal gas.
• Constipation: reduced bowel movements.

Serious or Rare Side Effects

• Severe allergic reaction: rash, itching, swelling, or difficulty breathing.
• Clostridioides difficile infection: persistent watery diarrhea indicating possible colitis.
• Low magnesium levels: muscle cramps, irregular heartbeat, or seizures.
• Bone fractures: increased risk with long‑term use.
• Vitamin B12 deficiency: anemia or neuropathy with prolonged therapy.
• Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

When prescribing omeprazole, clinicians should consider several safety aspects.

• Assess renal and hepatic function: dose adjustment may be needed in impairment.
• Review long‑term use: evaluate need after 8‑12 weeks to avoid unnecessary exposure.
• Monitor for infections: prolonged acid suppression can increase risk of gastrointestinal infections.
• Counsel on nutrient absorption: prolonged therapy may affect magnesium, calcium and vitamin B12 levels.
• Avoid concomitant use with certain antivirals: may alter drug concentrations.
• Store at ambient temperature: keep in the original container, protect from moisture and heat.

Omeprazole can affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid)

• Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk.
• Atazanavir and other protease inhibitors: decreased antiviral efficacy.
• Methotrexate (high dose): increased serum levels, risk of toxicity.

Moderate Interactions (Monitor Closely)

• Warfarin: potential increase in INR, requiring more frequent monitoring.
• Digoxin: may raise serum concentrations, necessitating dose review.
• Diazepam: enhanced sedation, monitor for excessive CNS depression.
• Phenytoin: altered metabolism, may require dose adjustment.